date:Mar 07, 2019
ed solutions via targeted strains, broadening the markets scope for health management in the pharmaceutical space.
OptiBiotixs LPLDL, a next-generation probiotic that uses a naturally-occurring strain of the bacterial species Lactobacillus Plantarum, has been shown in randomized controlled human studies to deliver tangible health benefits. This includes reducing total cholesterol by up to 36.7 percent, LDL cholesterol by 13.9 percent and lowering systolic blood pressure by 5.1 percent.
Cardio